Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MPLT stock hub

MapLight Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MPLTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MPLT

In the news

Latest news · MPLT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-56.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-36.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MPLT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

USD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001770069
Company name	MapLight Therapeutics, Inc.
Country	United States
Country code	US
Cusip	56565P103
Employees	133
Employees Change	70%
Employees Change Percent	111.1
Enterprise value	$942.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-10-27
Isin	US56565P1030
Last refreshed	2026-05-10
Market cap	$1.2B
Market cap category	Small-Cap
Price	$27.4
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	MPLT
Website	https://www.maplightrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.97%
FCF yield	-11.16%
P/B ratio	2.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-161.2M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-34.29
ROCE	-36.5
ROE	-56.19
ROIC	-36.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$479.5M
Cash	$305.1M
Current Assets	$324.7M
Current Liabilities	$16.2M
Debt	$5.8M
Debt Equity	$0.01
Equity	$458.4M
Liabilities	$21.1M
Long Term Assets	$154.8M
Long Term Liabilities	$4.9M
Net Cash	$299.3M
Net Cash By Market Cap	$24.09
Net Cash Growth	192.81%
Net Debt Equity	$-0.65
Tangible Book Value	$458.4M
Tangible Book Value Per Share	$10.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	20.01
Net Working Capital	$4.2M
Quick ratio	18.8
Working Capital	$308.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,079.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	23.44
All Time High	33.28
All Time High Change	-17.67%
All Time High Date	2026-04-22
All Time Low	12.24
All Time Low Change	123.86%
All Time Low Date	2025-11-26
ATR	2.38
Beta1y	2.01
Ch YTD	55.99
High	29.95
High52	33.28
High52 Date	2026-04-22
High52ch	-17.67%
Low	27
Low52	12.24
Low52 Date	2025-11-26
Low52ch	123.86%
Ma50ch	16.89%
RSI	50.35
RSI Monthly	0
RSI Weekly	63.86
Sharpe ratio	1.23x
Sortino ratio	2.38
Total Return	-1,079.16%
Tr YTD	55.99
Tr1m	13.51%
Tr1w	-10.75%
Tr3m	61.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$33.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.08
Operating Income	$-169.1M
Price target	$34.43
Price Target Change	$25.66
Price Target Change Top	$22.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,931,295%
Float Percent	30.73%
Shares Insiders	2.55%
Shares Institutions	33.84%
Shares Out	45,337,590
Shares Qo Q	3,963.69%
Shares Yo Y	1,079.16%
Short Float	12.08%
Short Ratio	5.64
Short Shares	3.71

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-174.6M
Average Volume	312,421.8x
Bv Per Share	10.41
CAPEX	$-473,000
Ch1m	13.51
Ch1w	-10.75
Ch3m	61.37
Ch6m	75.53
Change	-6.16%
Change From Open	-6.23
Close	29.2
Days Gap	0.07
Depreciation Amortization	578,000
Dollar Volume	8,007,047.2
Earnings Date	2026-05-28
Earnings Time	bmo
EBIT	$-169.1M
EBITDA	$-168.5M
EPS	$-18.56
F Score	2
FCF	$-138.6M
FCF EV Yield	-14.7x
FCF Per Share	$-3.06
Financing CF	469,820,000
Fiscal Year End	December
Founded	2,018
Investing CF	-323,207,000
Ipr	61.18
Iprfo	44.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-26
Ma20	29.09
Ma20ch	-5.8%
Net CF	8,476,000
Next Earnings Date	2026-05-28
Open	29.22
Optionable	No
Position In Range	13.56
Post Close	27.4
Postmarket Change Percent	-0.48
Postmarket Price	$27.27
Ppne	6,583,000
Price Date	2026-05-08
Ptbv Ratio	2.71
Relative Volume	0.94x
Share Based Comp	36,006,000
Tr6m	75.53%
Us State	California
Volume	292,228

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MPLT pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns MPLT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.8%

Float: +30.7% of shares outstanding

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MPLT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.3

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MPLT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MPLT stock rating?

MapLight Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MPLT analysis?

The full report lives at /stocks/MPLT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MPLT?

The latest report frames MPLT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MPLT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.